Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Neurology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

  • Andras Fogarasi1Email author,
  • Liesbeth De Waele2,
  • Gabriella Bartalini3,
  • Sergiusz Jozwiak4, 5,
  • Nicola Laforgia6,
  • Helene Verhelst7,
  • Borivoj Petrak8,
  • Jean-Michel Pedespan9,
  • Olaf Witt10,
  • Ramon Castellana11,
  • Stefania Crippa12,
  • Gabriella Gislimberti12 and
  • Zsuzsanna Gyorsok1, 13
BMC NeurologyBMC series – open, inclusive and trusted201616:126

https://doi.org/10.1186/s12883-016-0658-4

Received: 7 January 2016

Accepted: 2 August 2016

Published: 8 August 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
7 Jan 2016 Submitted Original manuscript
29 Sep 2015 Reviewed Reviewer Report - Bernard Zonnenberg
23 Nov 2015 Reviewed Reviewer Report - Darcy Krueger
11 Mar 2016 Reviewed Reviewer Report - John Lawson
11 Apr 2016 Reviewed Reviewer Report - Deepti Dubey
2 Jun 2016 Author responded Author comments - Andras Fogarasi
Resubmission - Version 2
2 Jun 2016 Submitted Manuscript version 2
6 Jun 2016 Reviewed Reviewer Report - Deepti Dubey
19 Jul 2016 Author responded Author comments - Andras Fogarasi
Resubmission - Version 3
19 Jul 2016 Submitted Manuscript version 3
Publishing
2 Aug 2016 Editorially accepted
8 Aug 2016 Article published 10.1186/s12883-016-0658-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Neurology Department, Bethesda Children’s Hospital
(2)
Gasthuisberg University Hospitals Leuven
(3)
Pediatric Unit, University Hospital
(4)
Children’s Memorial Health Institute
(5)
Department of Pediatric Neurology, Medical University of Warsaw
(6)
Neonatology and NICU Section, DIMO, University of Bari
(7)
Ghent University Hospital
(8)
Motol University Hospital
(9)
CHU Pellegrin–Hôpital des Enfants
(10)
German Cancer Research Center and Section of Pediatric Brain Tumors, University Hospital
(11)
Novartis Farmacéutica SA
(12)
Novartis Farma S.p.A.
(13)
National Institute of Neurosciences

Advertisement